Clinical Trial Update: Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) [Phase 2]

View source ↗

Summary

Phase 2 PELOPS trial update reports results for palbociclib combined with endocrine therapy as neoadjuvant treatment for invasive lobular breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Lobular Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-08-31